Does DOXAZOSIN Cause Hyperparathyroidism secondary? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hyperparathyroidism secondary have been filed in association with DOXAZOSIN (Doxazosin). This represents 0.6% of all adverse event reports for DOXAZOSIN.
26
Reports of Hyperparathyroidism secondary with DOXAZOSIN
0.6%
of all DOXAZOSIN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From DOXAZOSIN?
Of the 26 reports, 26 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXAZOSIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does DOXAZOSIN Cause?
Asthma (413)
Dyspnoea (393)
Hypotension (385)
Drug ineffective (367)
Productive cough (350)
Syncope (343)
Dizziness (341)
Wheezing (328)
Condition aggravated (325)
Thrombosis (274)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which DOXAZOSIN Alternatives Have Lower Hyperparathyroidism secondary Risk?
DOXAZOSIN vs DOXAZOSIN\DOXAZOSIN
DOXAZOSIN vs DOXEPIN
DOXAZOSIN vs DOXERCALCIFEROL
DOXAZOSIN vs DOXIFLURIDINE
DOXAZOSIN vs DOXORUBICIN